FDA Panel Rejects Lilly’s Cancer Drug Tested Only in China – The New York Times

The agency has long had strict rules about approving drugs that were tested solely overseas, requiring that the data be applicable to patients and medical practice in the United States, that the inve… [read more]

Leave a Reply

Your email address will not be published.